MYGN icon

Myriad Genetics
MYGN

Overview Fund Activity

197 hedge funds and large institutions have $2.16B invested in Myriad Genetics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 76 increasing their positions, 63 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
-16
Holders Change %
-7.51%
% of All Funds
3.04%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
76
Reduced
63
Closed
37
Calls
$11M
Puts
$2.77M
Net Calls
+$8.21M
Net Calls Change
+$4.89M

Top Buyers

1
BlackRock
1
BlackRock
New York
$405M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$119M
3
Millennium Management
3
Millennium Management
New York
$34M
4
Artisan Partners
4
Artisan Partners
Wisconsin
$59.7M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$253M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$55.9M
2
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$0
3
Norges Bank
3
Norges Bank
Norway
$0
4
GCM
4
Glenview Capital Management
New York
$46.4M
5
Morgan Stanley
5
Morgan Stanley
New York
$12.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
226
Truvestments Capital
Florida
– -$2K -67 Closed
Jones Financial Companies
227
Jones Financial Companies
Missouri
– -$2K -60 Closed
JCM
228
Jacobi Capital Management
Pennsylvania
– -$1K -38 Closed
6 7 8 9
10